Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura

被引：0
|
作者：
Delgado, J
Bustos, JG
Jimenez-Yuste, V
Hernandez-Navarro, F
机构：
[1] Hosp Univ La Paz, Dept Hematol, Madrid 28046, Spain
[2] Univ Autonoma Madrid, Dept Med, Madrid, Spain
来源：
HAEMATOLOGICA | 2002年 / 87卷 / 02期
关键词：
rituximab; immune thrombocytopenic purpura; refractory;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：215 / 216
页数：2
相关论文
共 50 条
  • [21] A pilot study of anti-CD20 MoAb Rituximab in patients with refractory immune thrombocytopenic purpura (ITP).
    Saleh, MN
    Gutheil, J
    Moore, M
    Feinberg, B
    Bunch, P
    Butler, J
    Lavelle, P
    Kunkel, L
    Benyunes, K
    Grillo-Lopez, A
    LoBuglio, A
    [J]. BLOOD, 2000, 96 (11) : 252A - 253A
  • [22] A pilot study of anti-CD20 MoAb rituximab in patients with refractory immune thrombocytopenic purpura (ITP).
    Saleh, MN
    Moore, M
    Feinberg, B
    Bunch, P
    Butler, J
    Lavelle, P
    Kunkel, L
    Benyunes, K
    Grillo-Lopez, A
    LoBuglio, AF
    [J]. BLOOD, 2001, 98 (11) : 521A - 521A
  • [23] Diabetes and immune thrombocytopenic purpura: a new association with good response to anti-CD20 therapy
    Tschudin, Letizia von Laer
    Schwitzgebel, Valerie M.
    von Scheven-Gete, Annette
    Blouin, Jean-Louis
    Hofer, Michael
    Hauschild, Michael
    Ansari, Marc
    Stoppa-Vaucher, Sophie
    Phan-Hug, Franziska
    [J]. PEDIATRIC DIABETES, 2015, 16 (02) : 138 - 145
  • [24] Sustained response to anti-CD20 monoclonal antibody in severe acute primary immune thrombocytopenic purpura: Report of one adult case
    Luzzatto, G
    Cella, G
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2006, 12 (01) : 120 - 121
  • [25] A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia
    Saleh, MN
    Gutheil, J
    Moore, M
    Bunch, PW
    Butler, J
    Kunkel, L
    Grillo-López, AJ
    LoBuglio, AF
    [J]. SEMINARS IN ONCOLOGY, 2000, 27 (06) : 99 - 103
  • [26] Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab)
    Marzano, Angelo V.
    Fanoni, Daniele
    Venegoni, Luigia
    Berti, Emilio
    Caputo, Ruggero
    [J]. DERMATOLOGY, 2007, 214 (04) : 310 - 318
  • [27] Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 antibody Rituximab.
    Giagounidis, AAN
    Anhuf, J
    Schneider, P
    Germing, U
    Soehngen, D
    Quabeck, K
    Aul, C
    [J]. BLOOD, 2001, 98 (11) : 523A - 523A
  • [28] Anti-CD20 monoclonal antibody therapy in multiple myeloma
    Kapoor, Prashant
    Greipp, Patricia T.
    Morice, William G.
    Rajkumar, S. Vincent
    Witzig, Thomas E.
    Greipp, Philip R.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (02) : 135 - 148
  • [29] The use of anti-CD20 in management of Egyptian children with chronic immune thrombocytopenic purpura
    Abdelmabood, Suzy
    Sarhan, Mohamed M.
    [J]. EGYPTIAN JOURNAL OF HAEMATOLOGY, 2018, 43 (01): : 5 - 9
  • [30] Effect of anti-CD20 (Rituximab) in refractory immune thrombocytopenic purpura (RITP). Report of three new cases.
    Monroy, RH
    Viveros, PV
    Violante, MR
    [J]. BLOOD, 2002, 100 (11) : 81B - 81B
12345